...
机译:转移结直肠癌患者的血浆浓度及其代谢物,不良事件和ABCG2多态性之间的缔合血浆浓度,不良事件和ABCG2多态性
Japanese Fdn Canc Res Canc Inst Hosp Dept Pharm Koto Ku 3-8-31 Ariake Tokyo 1358550 Japan;
Showa Univ Sch Pharm Dept Pharmacol Toxicol &
Therapeut Div Pharmacokinet &
Pharmacodynam;
Japanese Fdn Canc Res Canc Inst Hosp Dept Gastroenterol Chemotherapy Koto Ku 3-8-31 Ariake;
Japanese Fdn Canc Res Canc Inst Hosp Dept Gastroenterol Chemotherapy Koto Ku 3-8-31 Ariake;
Showa Univ Sch Pharm Dept Pharmacol Toxicol &
Therapeut Div Pharmacokinet &
Pharmacodynam;
Showa Univ Sch Pharm Dept Pharmacol Toxicol &
Therapeut Div Pharmacokinet &
Pharmacodynam;
Japanese Fdn Canc Res Canc Inst Hosp Dept Pharm Koto Ku 3-8-31 Ariake Tokyo 1358550 Japan;
Japanese Fdn Canc Res Canc Inst Hosp Dept Pharm Koto Ku 3-8-31 Ariake Tokyo 1358550 Japan;
Japanese Fdn Canc Res Canc Inst Hosp Dept Pharm Koto Ku 3-8-31 Ariake Tokyo 1358550 Japan;
Japanese Fdn Canc Res Canc Inst Hosp Dept Pharm Koto Ku 3-8-31 Ariake Tokyo 1358550 Japan;
Japanese Fdn Canc Res Canc Inst Hosp Dept Gastroenterol Chemotherapy Koto Ku 3-8-31 Ariake;
Japanese Fdn Canc Res Canc Inst Hosp Dept Gastroenterol Chemotherapy Koto Ku 3-8-31 Ariake;
Japanese Fdn Canc Res Canc Inst Hosp Dept Gastroenterol Chemotherapy Koto Ku 3-8-31 Ariake;
Japanese Fdn Canc Res Canc Inst Hosp Dept Gastroenterol Chemotherapy Koto Ku 3-8-31 Ariake;
Japanese Fdn Canc Res Canc Inst Hosp Dept Gastroenterol Chemotherapy Koto Ku 3-8-31 Ariake;
Japanese Fdn Canc Res Canc Inst Hosp Dept Gastroenterol Chemotherapy Koto Ku 3-8-31 Ariake;
Japanese Fdn Canc Res Canc Inst Hosp Dept Gastroenterol Chemotherapy Koto Ku 3-8-31 Ariake;
Japanese Fdn Canc Res Canc Inst Hosp Dept Pharm Koto Ku 3-8-31 Ariake Tokyo 1358550 Japan;
Japanese Fdn Canc Res Canc Inst Hosp Dept Pharm Koto Ku 3-8-31 Ariake Tokyo 1358550 Japan;
Japanese Fdn Canc Res Canc Inst Hosp Dept Pharm Koto Ku 3-8-31 Ariake Tokyo 1358550 Japan;
Japanese Fdn Canc Res Canc Inst Hosp Dept Pharm Koto Ku 3-8-31 Ariake Tokyo 1358550 Japan;
Hoshi Univ Div Appl Pharmaceut Educ &
Res Shinagawa Ku 2-4-41 Ebara Tokyo 1428501 Japan;
Showa Univ Sch Pharm Dept Pharmacol Toxicol &
Therapeut Div Pharmacokinet &
Pharmacodynam;
Japanese Fdn Canc Res Canc Inst Hosp Dept Pharm Koto Ku 3-8-31 Ariake Tokyo 1358550 Japan;
Japanese Fdn Canc Res Canc Inst Hosp Dept Gastroenterol Chemotherapy Koto Ku 3-8-31 Ariake;
Regorafenib; Pharmacokinetics; Adverse events; Polymorphisms;
机译:未结合形式的未结合形式的Regorafenib活性代谢物M2和M5与日本结肠直肠癌患者的手足综合征和ABCG2多态性有关。
机译:雷戈非尼改善转移性结直肠癌的患者疗效-患者选择,给药,患者教育,预防和不良事件管理
机译:中华苯苯浓度,严重不良反应和ABCG2和oATP1B1多态性之间的关联
机译:使用无标签的微流体技术分离转移性结肠直肠癌患者的循环肿瘤细胞进行募准和检测KRAS,BRAF,PIK3CA突变
机译:非转移性结直肠癌患者强化诊断后大肠结肠镜检查的证据基础和成本效益的基于模型的评估
机译:MTHFR和ABCG2单核苷酸多态性与转移性结直肠癌一线化疗疗效不同的相关性
机译:ABCG2蛋白质水平和结合响应于转移性结直肠癌患者的基于第一线伊替康治疗
机译:结直肠无柄锯齿状息肉分子标志物与结直肠癌风险的关系。